# Nephros Inc. (NEPH)

> Nephros Inc. (NEPH) trades at $2.91 (+0.34%) as of 4:57:29 PM EST on Nov 18, 2026, -17.90% over the past month. Market cap is $31.41M, with 1.0 days to cover in short interest.

Canonical: https://massive.com/quote/neph
Data as of: 2026-11-18T21:57:29.216Z (15-minute delayed)
Source: Massive (https://massive.com/docs/llms.txt)

## Price

**$2.91** +0.01 (+0.34%)
As of 4:57:29 PM EST on Nov 18, 2026 · 15-minute delayed
Nasdaq · usd

## Stock performance

How Nephros Inc. (NEPH) stock has performed from one day to one year, with its 52-week range.

| Period | Return |
| --- | --- |
| 1D | -0.34% |
| 1W | -5.86% |
| 1M | -17.90% |
| YTD | -40.78% |
| 1Y | -41.26% |
| 52-wk range | $2.66 – $6.42 |

From daily closes through Nov 18, 2026.

## Key statistics

Today's trading snapshot for NEPH: day range, open, previous close, volume and market cap.

| Measure | Value |
| --- | --- |
| Day range | $2.75 – $2.89 |
| Open | $2.87 |
| Prev close | $2.90 |
| Volume | 97.02K |
| Market cap | $31.41M |
| Shares out | 10.87M |

## Valuation and profitability ratios

Valuation and profitability ratios for Nephros Inc.: P/E, P/S, P/B, ROE and more.

| Measure | Value |
| --- | --- |
| P/E | 16.44 |
| P/S | 1.46 |
| P/B | 2.50 |
| P/FCF | — |
| ROE | 15.2% |
| ROA | 12.5% |
| Debt/Equity | 0.00 |
| Div yield | 0.00% |

As of Nov 18, 2026

## Insider trading

[Nephros Inc. (NEPH) insider trading](https://massive.com/quote/neph/insider-trading.md): open-market Form 4 buys and sells by Nephros Inc. insiders over the last 12 months.

## 8-K filings

Material corporate events Nephros Inc. has disclosed to the SEC on Form 8-K.

- Nov 17, 2026 · Director departure
  “On November 10, 2026, Lisa Nettis notified the Board of Directors (the "Board") of Nephros, Inc. (the "Company") of her resignation from the Board, effective on November 26, 2026. Ms. Nettis' decision to resign was not due to any disagreement with the Company on any matter relating to the Company's operations, policies or practices.”
- Nov 5, 2026 · [Quarterly earnings](https://massive.com/quote/sec-filings/8-k/earnings-releases.md)
  “On November 5, 2026, Nephros, Inc. (the "Company") issued a press release in which it disclosed its financial results for the three and nine months ended September 30, 2026.”
- Oct 13, 2026 · Shareholder meeting notice
  “On October 13, 2026, the Board of Directors (the "Board") of Nephros, Inc. (the "Company") set Wednesday, November 25, 2026, at 11:00 a.m., Eastern Time, as the date and time of the Company's 2026 Annual Meeting of Stockholders (the "2026 Annual Meeting"), which will be held virtually via live webcast. The Board also set the close of business on September 30, 2026 as the record date for determining the stockholders entitled to notice of, and to vote at, the 2026 Annual Meeting.”
- Jun 15, 2026 · Investor presentation
  “On June 12, 2026, Nephros, Inc. (the "Company") posted an updated 2026 Corporate Presentation on its corporate website. A copy of this presentation is furnished herewith as Exhibit 99.1.”
- Mar 27, 2026 · Investor presentation
  “On March 27, 2026, Nephros, Inc. (the "Company") posted an updated 2026 Corporate Presentation on its corporate website. A copy of this presentation is furnished herewith as Exhibit 99.1.”

## Dividend history and stock splits

Nephros Inc.'s recent dividend payments and stock splits.

### Dividends

No recent dividends.

### Splits

- 1-for-9 · Jul 10, 2019
- 1-for-20 · Mar 17, 2011

## NEPH short interest

How heavily NEPH is shorted: shares short, days to cover and average daily volume.

| Measure | Value |
| --- | --- |
| Days to cover | 1.0 |
| Short interest | 11.91K |
| Avg volume | 54.29K |

As of Oct 30, 2026 · reported to FINRA twice monthly.

## NEPH news

The latest news and headlines about Nephros Inc. (NEPH).

- [New Strong Buy Stocks for November 12th](https://www.zacks.com/commentary/3027677/new-strong-buy-stocks-for-november-12th?cid=CS-ZC-FT-zacks_1_rank_additions-3027677) · Zacks Investment Research · Nov 12, 2026 · positive sentiment
- [Nephros Inc. (NEPH) Tops Q3 Earnings and Revenue Estimates](https://www.zacks.com/stock/news/3025045/nephros-inc-neph-tops-q3-earnings-and-revenue-estimates?cid=CS-ZC-FT-fundamental_analysis|yseop_template_4-3025045) · Zacks Investment Research · Nov 5, 2026 · neutral sentiment
- [Envista (NVST) Tops Q3 Earnings and Revenue Estimates](https://www.zacks.com/stock/news/3023498/envista-nvst-tops-q3-earnings-and-revenue-estimates?cid=CS-ZC-FT-fundamental_analysis|yseop_template_4-3023498) · Zacks Investment Research · Nov 4, 2026 · neutral sentiment
- [QuidelOrtho (QDEL) Beats Q3 Earnings and Revenue Estimates](https://www.zacks.com/stock/news/3022231/quidelortho-qdel-beats-q3-earnings-and-revenue-estimates?cid=CS-ZC-FT-fundamental_analysis|yseop_template_4-3022231) · Zacks Investment Research · Nov 3, 2026 · negative sentiment
- [Nephros to Participate in the “Health, Wellness & Longevity” Virtual Conference Presented by Maxim Group LLC on Wednesday, July 22nd at 10:00 a.m. ET](https://www.globenewswire.com/news-release/2026/07/20/3329599/0/en/Nephros-to-Participate-in-the-Health-Wellness-Longevity-Virtual-Conference-Presented-by-Maxim-Group-LLC-on-Wednesday-July-22nd-at-10-00-a-m-ET.html) · GlobeNewswire Inc. · Jul 20, 2026 · positive sentiment

## About Nephros Inc.

Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of revenue from product sales and a small amount from royalty revenue and other revenues.

| Measure | Value |
| --- | --- |
| Exchange | Nasdaq |
| Market | stocks |
| Type | CS |
| Currency | USD |
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 36 |
| Listed | Sep 21, 2004 |

[Company website](https://www.nephros.com)

## FAQ

### What is the Nephros Inc. (NEPH) stock price today?

Nephros Inc. (NEPH) is trading at $2.91 (+0.34% on the day) as of 4:57:29 PM EST on Nov 18, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.

### What is Nephros Inc.?

Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products.

### What is the short interest in NEPH?

As of Oct 30, 2026, NEPH has 11.91K shares short and 1.0 days to cover.

### What exchange is NEPH listed on?

Nephros Inc. (NEPH) trades on Nasdaq in USD, in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry.

## Live data

Prices here are 15-minute delayed. For real-time NEPH quotes and the full history behind this page, use the Massive API or MCP server:

- `GET https://api.massive.com/v3/snapshot?ticker.any_of=NEPH`

Requests need a Massive API key. API reference for agents: https://massive.com/docs/llms.txt. Connect an AI agent through the Massive MCP server: https://massive.com/docs/ai-tools.

## Related

- [Nephros Inc. (NEPH) insider trading](https://massive.com/quote/neph/insider-trading.md)
- [SEC 8-K events](https://massive.com/quote/sec-filings/8-k.md)
- [Markets overview](https://massive.com/quote/index.md)

Nothing here is investment advice. Data and content are provided for informational purposes under the Massive Terms of Service: https://massive.com/terms
